MHRA company-led drug alert – Denzapine 50mg/ml oral suspension (Britannia Pharmaceuticals Ltd)

MHRA company-led drug alert – Denzapine 50mg/ml oral suspension (Britannia Pharmaceuticals Ltd)

June 25, 2018

CLDA number: CLDA (18)A/03

Date issued: 25th June 2018

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led drug recall for certain batches of:

Denzapine 50mg/ml oral suspension (Britannia Pharmaceuticals Ltd)

PL number: PL04483/0071

Britannia Pharmaceuticals Ltd is recalling certain batches of the above because of increased crystallisation of the active ingredient which may affect the delivery of the full dose.

To view the alert please visit the GOV.UK website.



Posted in:


More Latest News >

Ask PSNC: Flu FAQs

The team at PSNC has received a number of queries on the NHS Flu Vaccination Service 2018/19. Below are some...

October 2018 Category M prices

Category M reimbursement prices for October 2018 can be found here. These show a net overall reduction compared to October 2018...

PSNC CEO webinar now on-demand

Community pharmacy contractors can now access an online recording of PSNC’s recent CEO webinar. Almost 500 people registered for yesterday’s...